The American Journal of Managed Care11d
Myasthenia Gravis Care Overlooks Speech and Swallowing Dysfunction
Myasthenia gravis is a neuromuscular junction disorder with a hallmark of progressive muscle weakness and frequent ...
MedPage Today14d
Myasthenia Gravis Exacerbations
Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Generalized myasthenia gravis (gMG) affects most patients through a handful of well-characterized neuromuscular ...
MedPage Today3d
Myasthenia Gravis Antibody Types
Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Myasthenia gravis (MG) results from autoimmune antibodies against the post-synaptic neuromuscular junction with three ...
Healio8d
FDA approves Soliris for patients aged 6 years and up with generalized myasthenia gravis
The FDA has approved an expanded indication of Soliris, an IV-administered monoclonal antibody for patients aged 6 years and ...
Onlymyhealth5d
FDA Approves First-Ever Myasthenia Gravis Treatment For Children—A Game Changer In Pediatric Care
Generalised myasthenia gravis (gMG) is a chronic disorder in which the body's immune system mistakenly targets the neuromuscular junctions—areas where nerves signal muscles to move. This ...
The American Journal of Managed Care5d
FDA Approves Expanded Indication of Eculizumab for Pediatric Generalized Myasthenia Gravis
The FDA first approved eculizumab for use in adult patients with generalized myasthenia gravis in 2017, before expanding the ...
MedPage Today on MSN13d
Myasthenia Gravis Exacerbations
Generalized myasthenia gravis (gMG) affects most patients through a handful of well-characterized neuromuscular junction ...